Pieris Pharmaceuticals Announces Presentation of Encouraging Preclinical ...
Pieris Pharmaceuticals Announces Presentation of Encouraging Preclinical ...
Source: pr-inside.com
Shane Olwill News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Shane Olwill. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Shane Olwill Today - Breaking & Trending Today
Pieris Pharmaceuticals, Inc.: Pieris Pharmaceuticals Announces Presentation of Encouraging Preclinical Data for PRS-400 at ATS 2023 International Conference
BOSTON, MA / ACCESSWIRE / May 22, 2023 / Pieris Pharmaceuticals, Inc. (Nasdaq:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology
Source: finanznachrichten.de
Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Q1 2023 Earnings Call Transcript
Operator: Good day, ladies and gentlemen. And welcome to the Pieris Pharmaceuticals to host First Quarter 2023 Investor Call.
Source: insidermonkey.com
Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Q4 2022 Earnings Call Transcript
Operator: Hello and welcome to the Pieris Pharmaceuticals, Inc. Year-End 2022 Conference Call and Webcast. . A question-and-answer session will follow the formal presentation.
Source: insidermonkey.com
Pieris Pharmaceuticals, Inc.: Pieris Pharmaceuticals Announces Presentation of Preclinical Data for Inhaled Jagged-1 Inhibitor PRS-400 at ERS
BOSTON, MA / ACCESSWIRE / August 24, 2022 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology
Source: finanznachrichten.de